Skip to content
Search

Latest Stories

Government announces biggest flu programme in UK for winter 2021

The Health and Social Care Secretary Sajid Javid announced the most comprehensive flu vaccination programme in UK history on Saturday (July 17).

From September 2021, providers will offer the flu vaccine to over 35 million people during the upcoming winter season, including all secondary school students up to Year 11 for the first time. This builds on the success of last year’s expanded flu programme, which saw a record number of people get their jab.


Last year, 4 in 5 (80.9 per cent) people aged 65 and over in England received their flu vaccine - exceeding the World Health Organization uptake ambition of 75 per cent.

Working with the NHS, the government is preparing to deliver the expanded flu programme alongside any booster programme for Covid-19 vaccines as part of wider autumn and winter planning, which centres around protecting as many lives as possible.

During the 2021/22 season, which starts in September, the flu jab will be available to: all children aged two and three on 31 August 2021; all children in primary school and all children in school Years 7 to 11 in secondary school; those aged six months to under 50 years in clinical risk groups; pregnant women; those aged 50 years and over; unpaid carers; close contacts of immunocompromised individuals; and frontline health and adult social care staff.

Health seceretary Sajid Javid said: “Flu can be a serious illness and we want to build a wall of protection by immunising a record number of people.

“With the nation getting closer to normal life, we must learn to live with Covid-19 alongside other viruses and we’re offering the free flu jab to millions more people to help keep them safe this winter.

“The phenomenal scale of the Covid-19 vaccination programme is a clear demonstration of the positive impact vaccination can make and I encourage all those eligible to get their flu jab when called forward.”

The enlarged flu drive will build on last year’s expanded flu programme, where flu vaccinations opened up to 50 to 64-year-olds and year 7 pupils for the first time, with the aim of offering protection to as many eligible people as possible.

For frontline healthcare workers and two and three-year olds, the highest ever recorded levels of flu vaccine uptake were also achieved last year. This year, all frontline health and social care workers will be offered the flu vaccination again to ensure they, and the people they care for, are protected.

Eligible groups are urged to get their free vaccine every year and to protect themselves and the most vulnerable people in society ahead of the winter.

As a result of non-pharmaceutical interventions in place for Covid-19 - such as mask-wearing, physical and social distancing, and restricted international travel - flu levels were lower than expected across the world in 2020/21.

It is possible there will be higher levels of flu this winter, with more of the population susceptible given the low levels last season. The flu vaccine offers the best available protection against the virus and the public can reduce the spread of flu and other winter bugs by regularly washing hands, throwing away used tissues and practising good hygiene.

Alongside this flu drive, the government is preparing for a booster programme of Covid-19 vaccines and the Joint Committee on Vaccination (JCVI) and Immunisation. The booster programme – which would be designed to ensure millions of people most vulnerable to Covid-19 continue to have the protection they need ahead of the winter and against new variants - will be informed by the JCVI’s final advice expected later this summer based on the very latest scientific data.

The Department of Health and Social Care, NHS England and Improvement, and Public Health England have today issued the 2021/22 annual flu letter to providers, setting out plans for this year’s expanded programme. This blueprint will ensure GP practices, pharmacies and school-based providers are mobilised to begin administering flu vaccines from September.

Dr Yvonne Doyle, medical director at Public Health England, said: “The flu vaccine is safe, effective and protects millions of people each year from what can be a devastating illness.

“Last winter, flu activity was extremely low, but this is no reason for complacency as it means less people have built up a defence against the virus. Combined with the likelihood that Covid-19 will still be circulating, this makes the coming flu season highly unpredictable.

“We will be preparing for a challenging winter by expanding our world-leading flu vaccination programme to over 35 million people, saving more lives and limiting the impact on the NHS and social care.”

Dr Nikita Kanani, NHS medical director for primary care, said, “NHS staff across England vaccinated record numbers of people against flu last year – a potentially fatal illness - and they continue to pull out all the stops to deliver the biggest and most successful NHS Covid-19 vaccination programme in health history, protecting their patients and communities.

“Getting your free flu vaccine if you are eligible as well as keeping up good habits like regularly washing your hands could help save your life, so please do come forward when you are invited to give you and your loved ones vital protection this winter.”

The childhood flu programme aims to protect children and contain the spread of the virus to babies and vulnerable adults they may be in contact with. The nasal spray vaccine is offered to 2 and 3-year-olds and children in primary school and Year 7 and, for the first time this year, secondary school aged children up to Year 11.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less